Intranasal delivery through the olfactory pathway could theoretically deliver retatrutide directly to the brain, potentially achieving central nervous system effects at lower systemic doses
I personally think the new GLP-90 program will open up GLP-1 use to many more people who have wanted to try a GLP-1 for weight loss (or, honestly, a whole slew of other reasons) but have been hesitant to commit to injections and an aggressive protocol
We grew HCAECs to roughly 8090% confluency and performed scratch assay PAGln (100 M) (Fig
One of our go-to products is Biofilm Phase-2 Advanced by Priority One
Do Not Use Zepbound If You Have a personal or family history of medullary thyroid carcinoma Have Multiple Endocrine Neoplasia syndrome type 2 Have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound Warnings and Precautions Severe gastrointestinal disease not recommended for patients with severe gastroparesis Acute pancreatitis Acute gallbladder disease Hypoglycemia with concomitant insulin or insulin secretagogue use Hypersensitivity reactions including anaphylaxis and angioedema Acute kidney injury Diabetic retinopathy complications in patients with a history of diabetic retinopathy Suicidal behavior and ideation monitor for new or worsening depression or unusual mood changes Pulmonary aspiration during general anesthesia or deep sedation delayed gastric emptying may increase aspiration risk Most Common Adverse Reactions Nausea, diarrhea, vomiting, constipation Abdominal pain and dyspepsia Injection site reactions Fatigue Hypersensitivity reactions Eructation, hair loss, gastroesophageal reflux disease Hormonal Contraception Interaction Zepbound may reduce the effectiveness of oral hormonal contraceptives
Yes, semaglutide and rapid weight loss can increase the risk of gallbladder disease, including gallstones
